Johnson & Johnson is around $169.12 after gaining 0.48%

Published: January 25 2023, 20:50 GMT+0

Johnson & Johnson is around $169.12 after gaining 0.48%

As the end of the session approaches, a small gain for the medical devices and pharmaceutical manufacturer at $169.12 after ranging between $166.94 and $169.22 today.

Johnson & Johnson's uptick comes amid disappointing United States macroeconomic data released during the session – highly important Crude Oil Inventories data from United States beat analyst expectations of 971,000 with a reading of 533,000.

At the same time, United States 5-Year Note Auction released today at 18:00 UTC with a figure of 3.53, while the previous figure was 3.973. United States Cushing Crude Oil Inventories came out at 4.27 million.

A look at other health care stocks also shows bullish price action as Bristol-Myers Squibb Company is up 1.21%.

At the same time, after closing the previous session (yesterday) at $112.53, Abbott Laboratories lost $2.13 and is trading around $110.4. Amgen is down to $256.42, losing 1.26%, after ending yesterday at $259.7.

Also worthy of note, tomorrow at 13:30 UTC data for United States Core Durable Goods Orders will be released, with an expected decline to -0.2% from the preceding figure of 0.1%. As things stand, upcoming United States GDP data is projected to fall short of market expectations with newly published data of 2.6, following on from the preceding figure of 3.2. New data is set to be published tomorrow at 13:30 UTC. United States Initial Jobless Claims projected to come out at 205,000 — worse than previous data of 190,000; data will be released tomorrow at 13:30 UTC.

This year has been a gloomy one for the medical devices and pharmaceutical manufacturer after trading as high as $186 and going on to lose 5.54% of its value.

Back